Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.

Schaefer, Martin

Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. [electronic resource] - Hepatology (Baltimore, Md.) Oct 2007 - 991-8 p. digital

Publication Type: Controlled Clinical Trial; Journal Article

0270-9139

10.1002/hep.21791 doi


Adult
Antidepressive Agents--therapeutic use
Antiviral Agents--adverse effects
Depression--chemically induced
Drug Therapy, Combination
Female
Genotype
Hepatitis C, Chronic--drug therapy
Humans
Interferon alpha-2
Interferon-alpha--adverse effects
Logistic Models
Male
Mental Disorders--complications
Middle Aged
Polyethylene Glycols--adverse effects
Prospective Studies
Recombinant Proteins
Ribavirin--adverse effects
Risk Factors
Substance-Related Disorders--complications
Treatment Outcome